322 related articles for article (PubMed ID: 36212394)
1. A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art.
Pinkiewicz M; Pinkiewicz M; Walecki J; Zawadzki M
Front Oncol; 2022; 12():950167. PubMed ID: 36212394
[TBL] [Abstract][Full Text] [Related]
2. Rechallenging Recurrent Glioblastoma with Intra-Arterial Bevacizumab with Blood Brain-Barrier Disruption Results in Radiographic Response.
Faltings L; Kulason KO; Patel NV; Wong T; Fralin S; Li M; Schneider JR; Filippi CG; Langer DJ; Ortiz R; Boockvar JA
World Neurosurg; 2019 Nov; 131():234-241. PubMed ID: 31351210
[TBL] [Abstract][Full Text] [Related]
3. Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going.
D'Amico RS; Khatri D; Reichman N; Patel NV; Wong T; Fralin SR; Li M; Ellis JA; Ortiz R; Langer DJ; Boockvar JA
J Neurooncol; 2020 Apr; 147(2):261-278. PubMed ID: 32076934
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival.
Burkhardt JK; Riina H; Shin BJ; Christos P; Kesavabhotla K; Hofstetter CP; Tsiouris AJ; Boockvar JA
World Neurosurg; 2012 Jan; 77(1):130-4. PubMed ID: 22405392
[TBL] [Abstract][Full Text] [Related]
5. Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastoma.
Kulason KO; Schneider JR; Chakraborty S; Filippi CG; Pramanik B; Wong T; Fralin S; Tan K; Ray A; Alter RA; Ortiz R; Demopoulos A; Langer DJ; Boockvar JA
J Exp Ther Oncol; 2018 May; 12(3):223-229. PubMed ID: 29790314
[TBL] [Abstract][Full Text] [Related]
6. Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.
Shin BJ; Burkhardt JK; Riina HA; Boockvar JA
Neurosurg Clin N Am; 2012 Apr; 23(2):323-9, ix-x. PubMed ID: 22440875
[TBL] [Abstract][Full Text] [Related]
7. The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma.
Theodotou C; Shah AH; Hayes S; Bregy A; Johnson JN; Aziz-Sultan MA; Komotar RJ
Br J Neurosurg; 2014 Aug; 28(4):438-46. PubMed ID: 24432794
[TBL] [Abstract][Full Text] [Related]
8. Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma.
Riina HA; Fraser JF; Fralin S; Knopman J; Scheff RJ; Boockvar JA
J Exp Ther Oncol; 2009; 8(2):145-50. PubMed ID: 20192120
[TBL] [Abstract][Full Text] [Related]
9. Durability of single dose intra-arterial bevacizumab after blood/brain barrier disruption for recurrent glioblastoma.
Chakraborty S; Filippi CG; Burkhardt JK; Fralin S; Ray A; Wong T; Ortiz R; Langer DJ; Boockvar JA
J Exp Ther Oncol; 2016 Nov; 11(4):261-267. PubMed ID: 27849336
[TBL] [Abstract][Full Text] [Related]
10. Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment.
Ellis JA; Banu M; Hossain SS; Singh-Moon R; Lavine SD; Bruce JN; Joshi S
J Drug Deliv; 2015; 2015():405735. PubMed ID: 26819758
[TBL] [Abstract][Full Text] [Related]
11. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors.
Srinivasan VM; Lang FF; Chen SR; Chen MM; Gumin J; Johnson J; Burkhardt JK; Kan P
J Neurointerv Surg; 2020 Feb; 12(2):197-203. PubMed ID: 31676690
[TBL] [Abstract][Full Text] [Related]
12. Intraarterial drug delivery for glioblastoma mutiforme: Will the phoenix rise again?
Joshi S; Ellis JA; Ornstein E; Bruce JN
J Neurooncol; 2015 Sep; 124(3):333-43. PubMed ID: 26108656
[TBL] [Abstract][Full Text] [Related]
13. Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial.
Patel NV; Wong T; Fralin SR; Li M; McKeown A; Gruber D; D'Amico RS; Patsalides A; Tsiouris A; Stefanov DG; Flores O; Zlochower A; Filippi CG; Ortiz R; Langer DJ; Boockvar JA
J Neurooncol; 2021 Nov; 155(2):117-124. PubMed ID: 34601657
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity.
Muldoon LL; Pagel MA; Netto JP; Neuwelt EA
J Neurooncol; 2016 Feb; 126(3):447-54. PubMed ID: 26694547
[TBL] [Abstract][Full Text] [Related]
15. Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme.
Burkhardt JK; Shin BJ; Schlaff CD; Riina H; Boockvar JA
J Exp Ther Oncol; 2011; 9(3):183-6. PubMed ID: 22070049
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II trial of superselective arterial 5-FU infusion with concomitant external beam radiation for patients with either anaplastic astrocytoma or glioblastoma multiforme.
Larner JM; Kersh CR; Constable WC; Kline P; Ferguson R; Short R; Jane JA
Am J Clin Oncol; 1991 Dec; 14(6):514-8. PubMed ID: 1659783
[TBL] [Abstract][Full Text] [Related]
17. Republished: Real-time MRI guidance for intra-arterial drug delivery in a patient with a brain tumor: technical note.
Zawadzki M; Walecki J; Kostkiewicz B; Kostyra K; Pearl MS; Solaiyappan M; Walczak P; Janowski M
J Neurointerv Surg; 2019 Aug; 11(8):e3. PubMed ID: 31123186
[TBL] [Abstract][Full Text] [Related]
18. Real-time MRI guidance for intra-arterial drug delivery in a patient with a brain tumor: technical note.
Zawadzki M; Walecki J; Kostkiewicz B; Kostyra K; Pearl MS; Solaiyappan M; Walczak P; Janowski M
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30679227
[TBL] [Abstract][Full Text] [Related]
19. A murine model of targeted infusion for intracranial tumors.
Kim M; Barone TA; Fedtsova N; Gleiberman A; Wilfong CD; Alosi JA; Plunkett RJ; Gudkov A; Skitzki JJ
J Neurooncol; 2016 Jan; 126(1):37-45. PubMed ID: 26376657
[TBL] [Abstract][Full Text] [Related]
20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
